Yayıncı "Imprimatur Publications" WoS İndeksli Yayınlar Koleksiyonu için listeleme
Toplam kayıt 6, listelenen: 1-6
-
Addition of taxanes to combination chemotherapy in distal intestinal gastric cancer is more beneficial than proximal ones: A multicenter retrospective study of Turkish Oncology Group
(Imprimatur Publications, 2019)Purpose: Advanced gastric cancer has a dismal prognosis. Platin/5-fluorouracil (PF) combination chemotherapy is the main treatment modality for metastatic gastric cancer patients. Third drug addition to PF is a controversial ... -
Factors affecting survival in acute leukemia with donor lymphocyte infusion in the first relapse after allogeneic stem cell transplantation
(Imprimatur Publications, 2016)Purpose: Relapse of leukemia relapsing after allogeneic (allo) stem cell transplantation (SCT) remains an important problem. Cytoreductive chemotherapy followed by donor leukocyte infusion (DLI) is one of the treatment ... -
Prognostic impact of tumor lymphocytic infiltrates in patients with breast cancer undergoing neoadjuvant chemotherapy
(Imprimatur Publications, 2015)Purpose: The presence of a pronounced tumor lymphocytic infiltrate (TLI) is deemed to reflect the presence of an immunoinflammatory response against the tumor and may thus have prognostic significance. We investigated the ... -
A retrospective analysis on first-line bevacizumab, cetuximab, and panitumumab-containing regimens in patients with RAS-wild metastatic colorectal cancer: A Collaborative Study by Turkish Oncology Group (TOG)
(Imprimatur Publications, 2019)Purpose: To compare the efficacy and adverse effect profiles of the first-line treatment of patients with KRAS wild type metastatic colorectal cancer (CRC) in Turkey who were treated based on regimens including bevacizumab, ... -
Survival analysis of metastatic colorectal cancer patients who were treated with the five major therapeutic agents over the course of disease
(Imprimatur Publications, 2013)Purpose: Exposure to all active agents may be more important than specific sequence of drug administration in the treatment of patients with metastatic colorectal cancer (mCRC). The purpose of this study was to evaluate ... -
Weight loss at the time of diagnosis is not associated with prognosis in patients with advanced-stage non-small cell lung cancer
(Imprimatur Publications, 2015)Purpose: To investigate the prognostic value of weight loss before diagnosis in patients with advanced stage non-small cell lung cancer (NSCLC) treated with first-line chemotherapy. Methods: A total of 81 NSCLC patients ...